A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Clinical trial NCT05099003 · RECRUITING
Trial details
- NCT number
- NCT05099003
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-31
- Primary completion
- 2027-06-30
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.